Clinical Trial Update: Role Of Non-Specific Effects in The Treatment of Depression With Esketamine [NA]

View source ↗

Summary

A Yale-led trial evaluating non-specific effects in the treatment of depressive episodes with esketamine was terminated; results were posted on January 14, 2026…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Spravato (esketamine) (esketamine)

Snippet

Sponsor: Yale University | Conditions: Depressive Episode | NA | Status: TERMINATED | Results posted: 2026-01-14